Effect of atorvastatin on haemostasis, fibrinolysis and inflammation in normocholesterolaemic patients with coronary artery disease

Treatment with HMG-CoA reductase inhibitors (statins) reduces the morbidity and mortality of coronary artery disease (CAD). In addition to their lipid-lowering actions, pleiotropic effects of statins have been demonstrated. The aim of the present study was to assess if atorvastatin therapy has an im...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Walter, Thomas (VerfasserIn) , Szabo, Sebastian (VerfasserIn) , Süselbeck, Tim (VerfasserIn) , Borggrefe, Martin (VerfasserIn) , Lang, Siegfried (VerfasserIn) , Swoboda, Stefanie (VerfasserIn) , Hoffmeister, Hans Martin (VerfasserIn) , Dempfle, Carl-Erik (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2010
In: Clinical drug investigation
Year: 2010, Jahrgang: 30, Heft: 7, Pages: 453-460
ISSN:1179-1918
DOI:10.2165/11536270-000000000-00000
Online-Zugang:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.2165/11536270-000000000-00000
Verlag, lizenzpflichtig, Volltext: https://link.springer.com/article/10.2165/11536270-000000000-00000
Volltext
Verfasserangaben:Thomas Walter, Sebastian Szabo, Tim Suselbeck, Martin Borggrefe, Siegfried Lang, Stefanie Swoboda, Hans Martin Hoffmeister and Carl-Erik Dempfle
Beschreibung
Zusammenfassung:Treatment with HMG-CoA reductase inhibitors (statins) reduces the morbidity and mortality of coronary artery disease (CAD). In addition to their lipid-lowering actions, pleiotropic effects of statins have been demonstrated. The aim of the present study was to assess if atorvastatin therapy has an impact on haemostasis, fibrinolysis and inflammation in normocholesterolaemic patients with CAD.
Beschreibung:Online veröffentlicht am 24. August 2012
Gesehen am 04.10.2023
Beschreibung:Online Resource
ISSN:1179-1918
DOI:10.2165/11536270-000000000-00000